Onconetix, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Onconetix, Inc. (ONCO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $13.47 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.47M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.75M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15.76M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.37M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $13.47M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $11.75M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $15.76M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.37M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.91M 10-Q · filed 2025-11-13 |
| 2025-03-31 | $3.99M 10-Q · filed 2025-11-13 |
| 2024-12-31 | $8.54M 10-K · filed 2026-03-13 |
| 2024-09-30 | $41.02M 10-Q · filed 2025-11-13 |
| 2024-06-30 | -$28.73M 10-Q · filed 2025-11-13 |
| 2024-03-31 | -$14.50M 10-Q · filed 2025-11-13 |
| 2023-12-31 | $1.40M 10-K · filed 2026-03-13 |
| 2023-09-30 | $10.24M 10-Q · filed 2024-12-10 |
| 2023-06-30 | $13.08M 10-Q · filed 2024-12-10 |
| 2023-03-31 | $19.69M 10-Q · filed 2024-12-10 |
| 2022-12-31 | $22.39M 10-K · filed 2025-06-02 |
| 2021-12-31 | $1.45M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |